Guidelines and standards of care in Hurler syndrome (MPS I-H)
Clinical guidelines combine the best available research evidence with expert clinical experience to describe how Hurler syndrome should be recognised, treated, and monitored over time. They are used by healthcare teams, hospitals, and policy makers to guide daily clinical decisions and longer-term service planning.
This page explains what guidelines are, how they are produced, how data and registries inform them, and how families and professionals can use them in real-world care.
This information is intended for families, patient advocates, clinicians, and researchers. It does not replace advice from your own specialist healthcare team.What we mean by “guidelines”
Clinical guidelines are usually written by specialist groups and summarise current best practice for diagnosing and managing a condition. They are not rigid rules, but practical frameworks that help clinicians make consistent, evidence-based decisions.
- When Hurler syndrome should be suspected and how to confirm the diagnosis
- Follow-up of newborn screening results
- When to consider HSCT, ERT, or alternative approaches
- Recommended monitoring of heart, lungs, skeleton, brain, hearing, and vision
- Planning for anaesthesia, surgery, and emergency care
- Organisation of multidisciplinary clinics and lifelong follow-up
Different countries and professional societies may publish their own guidance, but core principles are often shared.
Who writes guidelines and how they are developed
Guidelines are usually created by multidisciplinary expert panels, including metabolic specialists, transplant teams, geneticists, anaesthetists, nurses, and allied health professionals. Increasingly, patients and family representatives also contribute.
- Reviewing existing research, registry data, and clinical trials
- Summarising outcomes, benefits, and potential risks
- Drafting recommendations and agreeing on best practice
- Grading recommendations by strength of evidence where possible
- Consultation with wider professional and patient communities
- Publication and periodic review as evidence evolves
How data and registries feed into guidelines
For rare conditions such as Hurler syndrome, high-quality registry and long-term follow-up data are essential. Without these data, guidance would rely largely on expert opinion alone.
- Long-term survival and organ outcomes after HSCT or ERT
- Rates of cardiac, respiratory, skeletal, and neurological complications
- Timing of diagnosis, newborn screening, and referral delays
- Real-world information on hospital care, procedures, and quality of life
These data help guideline groups define treatment thresholds, recommend surveillance schedules, and identify ongoing gaps in care.
What guidelines usually say about key areas of care
- Diagnosis and early management: Acting on newborn screening and prompt referral to specialist centres
- Disease-modifying treatment: Indications and timing for HSCT and the role of ERT
- Multisystem follow-up: Coordinated monitoring across all affected organ systems
- Anaesthesia and surgery: Airway planning, spine precautions, and perioperative risk management
- Supportive and palliative care: Pain control, rehabilitation, mental health, education, and end-of-life planning when needed
How families can use guidelines
Although guidelines are primarily written for professionals, families can still find them helpful when understanding and discussing care.
- Understanding why specific tests or treatments are recommended
- Preparing questions for clinic visits
- Supporting discussions with schools, local hospitals, or emergency teams
- Working with patient organisations to advocate for access to specialist services
Guidelines are not personalised care plans. Clinical teams may adapt recommendations to reflect individual needs.
How clinicians can use guidelines
Guidelines support clinical judgement and help ensure that important aspects of care are not overlooked.
- Developing local care pathways and shared-care protocols
- Establishing multidisciplinary clinics
- Designing follow-up schedules and surveillance reminders
- Supporting audit, service evaluation, and quality improvement
Guidelines, research and changing evidence
As new data and therapies emerge, guidelines evolve. This includes updated evidence on long-term outcomes, results from clinical trials, and improved understanding of quality of life and service delivery.
Guidelines, advocacy and policy
- Demonstrating professional agreement on standards of care
- Identifying gaps in access to treatments and specialist services
- Supporting funding applications and service development
- Informing national rare disease strategies and commissioning
Questions families and advocates can ask about guidelines
- Which guidelines does our care team follow?
- When were they last updated?
- Are all recommendations achievable in our region?
- How can families contribute to future updates?
- Are patient organisations involved in consultation?
- How do guidelines shape local service planning?
It is reasonable to ask how guideline recommendations relate to your own or your child’s care plan.
Guidelines at a glance
- Guidelines summarise best practice for diagnosis, treatment, and follow-up
- They are written by expert groups and increasingly include patient voices
- Registries and long-term data strengthen recommendations
- They support families, clinicians, service planning, and advocacy
Data, registries and advocacy
How evidence and advocacy support better care
Registries
What registries are and how they work
Clinical overview (HCP)
Technical summary for professionals
Follow-up & registries
Long-term data and standards of care
Unmet need
Why better treatments and services are still needed
Support organisations
Patient groups involved in care and advocacy